Common use of MAXIMUM CREDIT VALUE Clause in Contracts

MAXIMUM CREDIT VALUE. Patheon’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength […***…]

MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for Product any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength […PA 325/40 and PA 81/40 Tablets ***…]

MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement [for Product any Product] in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength Auryxia, Fexeric […***…] per Year to Patheon under this Product Agreement. YIELD TOLERANCE [***] SCHEDULE E Client Supply Chain Inventory Documentation Requirements [***]

MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 10mg strength CCX-168 Capsules […***…]] of revenues per Year to Patheon under this Product Agreement.

MAXIMUM CREDIT VALUE. Patheon’s liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for the Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength Crofelemer […***…]] % of revenues per Year to Patheon under this Product Agreement, up to a maximum of $[***] in the aggregate per Year. [End of Product Agreement] *** Confidential Treatment Requested

MAXIMUM CREDIT VALUE. Patheon’s liability for Active Materials Material calculated in accordance with Section 2.2 of the Master Agreement for Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength BC-3781 […***…]% of revenues (being payments of the Price) per Year received by Patheon under this Agreement. SCHEDULE E

MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for the Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE Pimavanserin tablets 17 mg strength Varubi […***…]